Citigroup
VKTX icon

Citigroup’s Viking Therapeutics VKTX Stock Holding History

Citigroup’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-80,300
Closed -$2.11M – 6505
2025
Q3 		$2.11M Buy
+80,300
New +$2.4M ﹤0.01% 2634
2024
Q3 		– Sell
-15,400
Closed -$816K – 5808
2024
Q2 		$816K Buy
+15,400
New +$1.01M ﹤0.01% 3056
2024
Q1 		– Sell
-90,000
Closed -$1.67M – 5869
2023
Q4 		$1.67M Buy
+90,000
New +$1.18M ﹤0.01% 2395
2023
Q3 		– Sell
-40,000
Closed -$648K – 5811
2023
Q2 		$648K Buy
40,000
+34,700
+655% +$727K ﹤0.01% 3180
2023
Q1 		$88.2K Buy
+5,300
New +$54.7K ﹤0.01% 4075
2021
Q1 		– Sell
-64,800
Closed -$365K – 7458
2020
Q4 		$365K Buy
64,800
+21,800
+51% +$132K ﹤0.01% 4489
2020
Q3 		$250K Sell
43,000
-18,300
-30% -$126K ﹤0.01% 4449
2020
Q2 		$442K Buy
61,300
+4,100
+7% +$27.2K ﹤0.01% 4372
2020
Q1 		$268K Buy
57,200
+700
+1% +$4.3K ﹤0.01% 4477
2019
Q4 		$453K Buy
56,500
+20,000
+55% +$146K ﹤0.01% 4501
2019
Q3 		$251K Sell
36,500
-12,600
-26% -$93.6K ﹤0.01% 4953
2019
Q2 		$408K Buy
49,100
+24,300
+98% +$208K ﹤0.01% 4619
2019
Q1 		$247K Buy
24,800
+13,200
+114% +$110K ﹤0.01% 4901
2018
Q4 		$89K Sell
11,600
-10,800
-48% -$129K ﹤0.01% 5749
2018
Q3 		$390K Buy
+22,400
New +$267K ﹤0.01% 4569

Other funds holding VKTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Citigroup's VKTX Position: Q1 2026 in Review

Citigroup increased its Viking Therapeutics (VKTX) stake by 59% in Q1 2026, buying an estimated $1.31M and bringing the position to 109,295 shares worth $3.56M. The position accounts for ﹤0.01% of the portfolio, ranked #2237.

Citigroup first reported a position in VKTX in Q1 2016 and has held it in 33 quarters since. The position peaked at $22.9M in Q2 2025. 410 funds tracked by Wall St. Rank hold VKTX as of Q1 2026.

  • Citigroup held 109,295 shares of Viking Therapeutics worth $3.56M as of Q1 2026.
  • Citigroup bought 40,640 Viking Therapeutics shares in Q1 2026, an estimated $1.31M.
  • Viking Therapeutics made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #2237 holding.
  • Citigroup first reported a position in Viking Therapeutics in Q1 2016 and has held it in 33 quarters since.
  • Citigroup's Viking Therapeutics position peaked at $22.9M in Q2 2025.
  • 410 funds tracked by Wall St. Rank held Viking Therapeutics as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.